Home › Companies › DENALI THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and DENALI THERAPEUTICS INC.’s Form 8-K, filed 2024-05-31 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore DENALI THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are DENALI THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-31 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jay Flatley | 108,094,205 | -- | -- | 2,149,100 | 8,072,151 | Majority: yes |
| Elect Director: Mac Tessier-Lavigne, Ph.D. | 82,215,374 | -- | -- | 28,027,931 | 8,072,151 | Majority: yes |
| Elect Director: Nancy A. Thornberry | 108,270,582 | -- | -- | 1,972,723 | 8,072,151 | Majority: yes |
Source: DENALI THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-05-31 — read the filing on EDGAR.
Each item below shows how the 239 asset managers that disclosed a DENALI THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of DENALI THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
88% fund support · no official result
The 194 asset managers below cast 88% of the shares they voted on this item FOR (78,213,361 for, 10,934,863 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 14,485,967 | 0 | 0 | 0 | For |
| BlackRock | 9,634,709 | 27,519 | 0 | 0 | For |
| State Street | 9,575,979 | 17,496 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 9,237,808 | 0 | 0 | 0 | For |
| Fidelity | 4,868,571 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 3,812,615 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 3,731,695 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,643,986 | 0 | 0 | 0 | For |
| Capital Group | 0 | 2,909,528 | 0 | 0 | Against |
| Capital Research Global Investors | 0 | 2,909,528 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 2,749,789 | 0 | 0 | 0 | For |
| UBS | 18,544 | 1,678,892 | 0 | 0 | Against |
| Camber Capital Management LP | 1,500,000 | 0 | 0 | 0 | For |
| Dimensional | 1,171,886 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 0 | 1,160,650 | 0 | 0 | Against |
| Aberdeen | 1,032,038 | 0 | 0 | 0 | For |
| BNY Mellon | 50,151 | 944,587 | 0 | 0 | Against |
| Northern Trust | 912,149 | 78 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 638,662 | 0 | 0 | 0 | For |
| Cercano Management LLC | 625,000 | 0 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 548,857 | 0 | 0 | Against |
| Woodline Partners LP | 527,217 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 510,285 | 0 | 0 | 0 | For |
| Nuveen | 508,196 | 0 | 0 | 0 | For |
| TIAA | 504,281 | 0 | 0 | 0 | For |
Showing the 25 largest of 194 asset managers. See all 194 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% fund support · no official result
The 67 asset managers below cast 99.9% of the shares they voted on this item FOR (45,875,590 for, 24,192 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,393,648 | 0 | 0 | 0 | For |
| BlackRock | 5,914,332 | 0 | 0 | 0 | For |
| State Street | 3,638,222 | 6,223 | 0 | 0 | For |
| Fidelity | 3,635,954 | 0 | 0 | 0 | For |
| Capital Group | 2,909,528 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,508,585 | 0 | 0 | 0 | For |
| Charles Schwab | 1,047,120 | 0 | 0 | 0 | For |
| Dimensional | 960,117 | 0 | 0 | 0 | For |
| BNY Mellon | 951,619 | 0 | 0 | 0 | For |
| Aberdeen | 516,019 | 0 | 0 | 0 | For |
| TIAA | 504,281 | 0 | 0 | 0 | For |
| Principal | 385,818 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 380,297 | 0 | 0 | 0 | For |
| Equitable | 330,702 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 277,830 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 201,173 | 0 | 0 | 0 | For |
| Artisan | 187,455 | 0 | 0 | 0 | For |
| Hartford | 173,517 | 0 | 0 | 0 | For |
| Lincoln Financial | 153,653 | 0 | 0 | 0 | For |
| Voya | 145,063 | 0 | 0 | 0 | For |
| Thrivent | 130,979 | 0 | 0 | 0 | For |
| Jackson National | 117,551 | 0 | 0 | 0 | For |
| John Hancock | 111,410 | 0 | 0 | 0 | For |
| Russell Investments | 106,873 | 0 | 0 | 0 | For |
| Northwestern Mutual | 101,689 | 0 | 0 | 0 | For |
Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
DENALI THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jay Flatley”): 108,094,205 for, 2,149,100 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 142,512,856 outstanding shares: 76% for, 2% withheld (77% of the company cast a for/withheld vote).
The 66 asset managers below cast 100% of the shares they voted on this item FOR (44,758,381 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,393,648 | 0 | 0 | 0 | For |
| BlackRock | 5,914,332 | 0 | 0 | 0 | For |
| State Street | 3,640,380 | 0 | 4,065 | 0 | For |
| Fidelity | 3,635,954 | 0 | 0 | 0 | For |
| Capital Group | 2,909,528 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,508,585 | 0 | 0 | 0 | For |
| Charles Schwab | 1,047,120 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 960,117 | 0 | Abstain |
| BNY Mellon | 951,619 | 0 | 0 | 0 | For |
| Aberdeen | 516,019 | 0 | 0 | 0 | For |
| TIAA | 504,281 | 0 | 0 | 0 | For |
| Principal | 385,818 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 380,297 | 0 | 0 | 0 | For |
| Equitable | 197,782 | 0 | 132,920 | 0 | For |
| Direxion Shares ETF Trust | 277,830 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 201,173 | 0 | 0 | 0 | For |
| Artisan | 187,455 | 0 | 0 | 0 | For |
| Hartford | 173,517 | 0 | 0 | 0 | For |
| Lincoln Financial | 146,221 | 0 | 7,432 | 0 | For |
| Voya | 145,063 | 0 | 0 | 0 | For |
| Thrivent | 130,979 | 0 | 0 | 0 | For |
| Jackson National | 102,110 | 0 | 15,441 | 0 | For |
| John Hancock | 111,410 | 0 | 0 | 0 | For |
| Russell Investments | 106,873 | 0 | 0 | 0 | For |
| Northwestern Mutual | 101,689 | 0 | 0 | 0 | For |
Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.
Combines 5 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
DENALI THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mac Tessier-Lavigne, Ph.D.”): 82,215,374 for, 28,027,931 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 142,512,856 outstanding shares: 58% for, 20% withheld (77% of the company cast a for/withheld vote).
The 66 asset managers below cast 100% of the shares they voted on this item FOR (36,552,123 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,393,648 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 5,914,332 | 0 | Abstain |
| State Street | 3,591,746 | 0 | 52,699 | 0 | For |
| Fidelity | 3,568,561 | 0 | 67,393 | 0 | For |
| Capital Group | 2,909,528 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,508,585 | 0 | 0 | 0 | For |
| Charles Schwab | 1,047,120 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 960,117 | 0 | Abstain |
| BNY Mellon | 944,587 | 0 | 7,032 | 0 | For |
| Aberdeen | 516,019 | 0 | 0 | 0 | For |
| TIAA | 504,281 | 0 | 0 | 0 | For |
| Principal | 264 | 0 | 385,554 | 0 | Abstain |
| WASATCH FUNDS TRUST | 380,297 | 0 | 0 | 0 | For |
| Equitable | 12,669 | 0 | 318,033 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 277,830 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 201,173 | 0 | Abstain |
| Artisan | 187,455 | 0 | 0 | 0 | For |
| Hartford | 173,517 | 0 | 0 | 0 | For |
| Lincoln Financial | 99,000 | 0 | 54,653 | 0 | For |
| Voya | 0 | 0 | 145,063 | 0 | Abstain |
| Thrivent | 0 | 0 | 130,979 | 0 | Abstain |
| Jackson National | 27,597 | 0 | 89,954 | 0 | Abstain |
| John Hancock | 67,319 | 0 | 44,091 | 0 | For |
| Russell Investments | 106,873 | 0 | 0 | 0 | For |
| Northwestern Mutual | 101,689 | 0 | 0 | 0 | For |
Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
DENALI THERAPEUTICS INC.’s own tally for this item (“Elect Director: Nancy A. Thornberry”): 108,270,582 for, 1,972,723 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 142,512,856 outstanding shares: 76% for, 1% withheld (77% of the company cast a for/withheld vote).
The 66 asset managers below cast 100% of the shares they voted on this item FOR (44,758,381 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,393,648 | 0 | 0 | 0 | For |
| BlackRock | 5,914,332 | 0 | 0 | 0 | For |
| State Street | 3,640,380 | 0 | 4,065 | 0 | For |
| Fidelity | 3,635,954 | 0 | 0 | 0 | For |
| Capital Group | 2,909,528 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,508,585 | 0 | 0 | 0 | For |
| Charles Schwab | 1,047,120 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 960,117 | 0 | Abstain |
| BNY Mellon | 951,619 | 0 | 0 | 0 | For |
| Aberdeen | 516,019 | 0 | 0 | 0 | For |
| TIAA | 504,281 | 0 | 0 | 0 | For |
| Principal | 385,818 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 380,297 | 0 | 0 | 0 | For |
| Equitable | 197,782 | 0 | 132,920 | 0 | For |
| Direxion Shares ETF Trust | 277,830 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 201,173 | 0 | 0 | 0 | For |
| Artisan | 187,455 | 0 | 0 | 0 | For |
| Hartford | 173,517 | 0 | 0 | 0 | For |
| Lincoln Financial | 146,221 | 0 | 7,432 | 0 | For |
| Voya | 145,063 | 0 | 0 | 0 | For |
| Thrivent | 130,979 | 0 | 0 | 0 | For |
| Jackson National | 102,110 | 0 | 15,441 | 0 | For |
| John Hancock | 111,410 | 0 | 0 | 0 | For |
| Russell Investments | 106,873 | 0 | 0 | 0 | For |
| Northwestern Mutual | 101,689 | 0 | 0 | 0 | For |
Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% fund support · no official result
The 49 asset managers below cast 97% of the shares they voted on this item FOR (24,105,917 for, 750,649 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Wellington | 7,887,309 | 0 | 0 | 0 | For |
| Vanguard | 6,242,434 | 0 | 0 | 0 | For |
| Temasek Holdings (Private) Ltd | 5,706,345 | 0 | 0 | 0 | For |
| Charles Schwab | 2,094,285 | 0 | 0 | 0 | For |
| Yiheng Capital Management, L.P. | 967,504 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 0 | 636,838 | 0 | 0 | Against |
| Hartford | 173,517 | 0 | 0 | 0 | For |
| Russell Investments | 132,661 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 125,846 | 0 | 0 | 0 | For |
| Prudential/PGIM | 103,858 | 0 | 0 | 0 | For |
| Northwestern Mutual | 101,689 | 0 | 0 | 0 | For |
| Pier Capital, LLC | 93,715 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 85,404 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 84,099 | 0 | 0 | 0 | For |
| NISA INVESTMENT ADVISORS, LLC | 0 | 66,135 | 0 | 0 | Against |
| Global X | 60,578 | 0 | 0 | 0 | For |
| SEI | 52,474 | 42 | 0 | 0 | For |
| WASHINGTON STATE INVESTMENT BOARD | 49,383 | 0 | 0 | 0 | For |
| Arizona State Retirement System | 30,384 | 0 | 0 | 0 | For |
| New York Life | 24,635 | 0 | 0 | 0 | For |
| Knights of Columbus Asset Advisors LLC | 0 | 21,848 | 0 | 0 | Against |
| Brighthouse | 0 | 0 | 19,493 | 0 | Abstain |
| Advisors' Inner Circle Fund III | 0 | 17,969 | 0 | 0 | Against |
| RBB FUND, INC. | 17,031 | 0 | 0 | 0 | For |
| Dunham Funds | 16,671 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Ranked by the number of DENALI THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 142,512,856 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.16% |
| 2 | BlackRock | 6.78% |
| 3 | State Street | 6.73% |
| 4 | BAILLIE GIFFORD & CO LTD | 6.48% |
| 5 | Fidelity | 3.42% |
| 6 | BAILLIE GIFFORD OVERSEAS LTD | 2.68% |
| 7 | BAKER BROS. ADVISORS LP | 2.62% |
| 8 | T. Rowe Price | 2.56% |
| 9 | Capital Group | 2.04% |
| 10 | Capital Research Global Investors | 2.04% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Baillie Gifford & Co | 10.01% | DEF14A |
| Biogen | 8.95% | DEF14A |
| BlackRock | 8.62% | 13F |
| Vanguard Group | 8.42% | 13F |
| Wellington Management | 5.80% | 13F |
| Wellington | 5.18% | DEF14A |
| Biogen MA Inc. | 5.02% | 13G |
| FMR (Fidelity) | 4.45% | 13F |
| State Street | 4.44% | 13F |
| Douglas K. Bratton | 4.04% | 13G |
Percentages above are of 142,512,856 shares outstanding, as reported by DENALI THERAPEUTICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DENALI THERAPEUTICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At DENALI THERAPEUTICS INC.'s shareholder meeting held 2024-05-31, in the 2023-2024 proxy season, 239 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,539 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. DENALI THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Advisory Vote to Ratify Named Executive Officers' Compensation — the reporting funds cast 88% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
DENALI THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.